Personalized medicine is changing the way researchers think about disease and treatment. Instead of assuming that the same treatment will work identically for every patient, researchers increasingly investigate biological differences that may influence treatment response.
Personalized medicine is changing the way researchers think about disease and treatment. Instead of assuming that the same treatment will work identically for every patient, researchers increasingly investigate biological differences that may influence treatment response.
Genetic information can be one component of this approach. Other factors, including biomarkers, disease characteristics, lifestyle, and previous treatment history, may also contribute to understanding differences between patients.
For pharmaceutical companies, this can create opportunities to investigate therapies designed for specific patient groups.
Biomarker research is particularly important in this area. A biomarker can provide measurable information about a biological process or disease characteristic and may help researchers identify patients who could benefit from a particular treatment.
Personalized medicine also creates challenges. Diagnostic testing, data interpretation, clinical implementation, affordability, and access all need to be considered.
Continued research in this field may help move medicine toward treatment strategies that are increasingly tailored to individual patient characteristics.